Search

everythinglearnresearchcommunity

for

Search:↓

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Involucrin is a useful marker for keratinocyte differentiation in mice.

Stromal cells in melanoma promote tumor growth and spread.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Pimecrolimus cream is not effective for treating alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Ruxolitinib treatment may cause eyelash growth.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Apremilast shows promise for several skin conditions but needs more research.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.